OU Faculty Member Co-Leading Innovative National Trial to Advance Lung Cancer Treatment
December 13, 2024
December 13, 2024
NORMAN, Oklahoma, Dec. 13 (TNSres) -- The University of Oklahoma issued the following news release:
* * *
First study from NCI's Clinical Trials Innovation Unit
* * *
Raid Aljumaily, M.D., an associate professor of hematology-oncology at the University of Oklahoma College of Medicine, is the national co-leader of the PROSPECT-Lung clinical trial that will evaluate the timing of immunotherapy for patients with operable non-small cell lung cancer . . .
* * *
First study from NCI's Clinical Trials Innovation Unit
* * *
Raid Aljumaily, M.D., an associate professor of hematology-oncology at the University of Oklahoma College of Medicine, is the national co-leader of the PROSPECT-Lung clinical trial that will evaluate the timing of immunotherapy for patients with operable non-small cell lung cancer . . .